Phathom Pharmaceuticals
Founded 2018 · 436 employees on LinkedIn · 3 known investors
Phathom Pharmaceuticals is a pharmaceutical company that develops and markets prescription treatments, including VOQUEZNA (vonoprazan) for gastrointestinal conditions, in the U.S. market.
Founders & leadership
MB
Mr. BastaCEO
Investors · 3
Frequently asked questions
- What does Phathom Pharmaceuticals do?
- Phathom Pharmaceuticals is a pharmaceutical company that develops and markets prescription treatments, including VOQUEZNA (vonoprazan) for gastrointestinal conditions, in the U.S. market.
- Who are Phathom Pharmaceuticals's investors?
- Phathom Pharmaceuticals's investors include Catalys Pacific, Frazier Life Sciences, New Enterprise Associates (NEA).